Significant Ownership of FIDELION DIAGNOSTICS PTE. LTD.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for FIDELION DIAGNOSTICS PTE. LTD. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Ling Xiao - Ling Xiao - Director
- Manager location
- Singapore
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
CIK context first
Continue from FIDELION DIAGNOSTICS PTE. LTD.
Significant Ownership of FIDELION DIAGNOSTICS PTE. LTD.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| BGLC | BioNexus Gene Lab Corp | COMMON STOCK, NO PAR VALUE | 13% | $584,570 | 392,329 | Fidelion Diagnostics Pte. Ltd. | 28 Nov 2025 |
Schedules 13D/G Reported by FIDELION DIAGNOSTICS PTE. LTD.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.